Ecological effect of gatifloxacin on the normal human intestinal microflora

Journal of Chemotherapy

Volumn 11, Issue 1, 1999, Pages 50-53

  Edlund, Charlotta ^a,b   Nord, C E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SÖDERTÖRN UNIVERSITY   (Sweden)

Author keywords

Ciprofloxacin; Fluoroquinolone; Gatifloxacin; Intestinal microflora; Levofloxacin; Microflora; Ofloxacin; Quinolones

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; CHLAMYDIA; CLINICAL TRIAL; CLOSTRIDIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES ANALYSIS; FUSOBACTERIUM; HUMAN; INTESTINE FLORA; MALE; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS; YEAST;

EID: 0033005072     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.1.50     Document Type: Article

References (12)

1. 1 Hawkey PM. Resistant bacteria in the normal human flora. J Antimicrob Chemother 1986; 18: 133-9.
2. 2 Edlund C, Nord CE. Ecological impact of antimicrobial agents on human intestinal microflora. Alpe Adria Microbiol J 1993; 2: 137-164.
3. 3 Edlund C, Sjöstedt S, Nord CE. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora. Scand J Infect Dis 1997; 29: 383-386.
4. 4 Ritz M, Lode H, Fassbender M, Borner K, Koeppe P, Nord CE. Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Antimicrob Agents Chemother 1994; 38: 455-459.
5. 5 Wise R, Brenwald NP, Andrews JM, Boswell F. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. J Antimicrob Chemother 1997; 39: 447-452.
6. 6 Bauernfeind A. Comparison of the antibacterial activities of quinolones Bay 12-8039, gatifloxacin, trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639-51.
7. 7 Heimdahl A, Nord CE. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis 1979; 11: 233-242.
8. 8 van der Waaij D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Ann Rev Microbiol 1989; 43: 69-87.
9. 9 Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrob Agents Chemother 1994; 38: 409-14.
10. 10 Edlund C, Lindqvist L, Nord CE. Norfloxacin binds to human fecal material. Antimicrob Agents Chemother 1988; 32: 1869-74.
11. 11 Ljungberg B, Nilsson-Ehle I, Edlund C, Nord CE. Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption. Scand J Infect Dis 1990; 22: 205-8.
12. 12 Kresken M, Hafner D, Mittermayer H, et al. Prevalence of fluoroquinolone resistance in Europe. Infection 1994; 22 (suppl 2): 90-8.